NCRAD Biospecimen Review Committee
Samples are made available to investigators upon approval by the NCRAD Biospecimen Review Committee (BRC). Six times a year, the NCRAD BRC reviews requests for multiple studies banked at NCRAD. The NCRAD BRC consists of statisticians, biomarker experts, and clinicians who have the expertise to review requests for a broad range of samples and experimental approaches.
Committee Chair
Deborah L. Blacker, MD, ScD
Harvard University/Harvard Medical School
Committee Members
Steve Edland, PhD
University of California, San Diego
Doug Galasko, MD
University of California, San Diego
Danielle Harvey, PhD
University of California, Davis
Nicholas M. Kanaan, PhD
Michigan State University
Suzanne Schindler, MD, PhD
Washington University School of Medicine in St. Louis